Interleukin-7—Dependent Interaction of Dendritic Epidermal T Cells with Keratinocytes  by Takashima, Akira et al.
Interleukin-7-Dependent Interaction of Dendritic 
Epidermal T Cells with Keratinocytes 
Akira Takashima, Hiroyuki Matsue, * Paul R. Bergstresser, and Kiyoshi Ariizumi 
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A. 
Dendritic epidermal T cells (DETC). a member of the 
epithelial tissue-type '}'O T-cell family. are character­
ized by their exclusive residence within mouse epi­
dermis. their dendritic morphology. and their mono­
clonal nature in the T -cell-receptor configuration. 
Here we review our recent studies on the interleukin 
(IL)-7-dependent interaction of DETC with neigh­
boring keratinocytes. Keratinocytes express constitu­
tively the mRNAs for IL-7 and secrete biologically 
relevant amounts of IL-7. This cytokine. in turn. 
serves as a growth factor for DETC. as evidenced by 
the proliferative responses to recombinant or kerati­
nocyte-derived IL-7 of the 7-17 DETC line and of 
DETC freshly purified from mouse skin. The 7-17 
DETC line undergoes apoptotic cell death in re­
sponse to external stimuli known to deplete DETC in 
situ (e.g.. ultraviolet B radiation or corticosteroid 
treatment). and IL-7 prevents this apoptosis. thereby 
promoting long-term survival. These results docu-
DENDRITIC EPIDERMAL T CELLS (DETC) AS EPITHELIAL 
TISSUE-RESIDENT ')'8 T CELLS 
Mouse epidermis contains, in addition to Langerhans cells , a unique 
leukocyte population termed DETC [1,2]. Our work and the work 
of many others (reviewed in [3,4]) has led to an appreciation that 
these cells are one component in a widely distributed family of 
epithelial tissue-resident ')'8 T cells (reviewed in [5]). Tissues now 
known to contain resident ')'8 T cells include skin, intestine, lung, 
reproductive tract, tongue, and mammary glands. 
DETC share with conventional cxf3 T cells several cell surface 
molecules (e.g., Thy-l, CD3, and CD45), but they have been 
distinguished by their lack of CD4 and CD8 and by their expression 
of a ')'8 T-cell receptor. Moreover, a striking early observation was 
that DETC display extremely restricted 1'8 gene usage and no 
junctional diversity. All DETC clones established in our laboratory 
have demonstrated an identical T-cell receptor, composed of 
Vy3/Jyl-Cyl and V81/D821J82-C8 gene segments [6-8]. This 
feature has been confirmed in situ using a monoclonal antibody 
specific to Vy3, with the overwhelming majority ofThy-l +, CD3+ 
epidermal cells expressing this determinant [9]. 
The resulting monoclonal nature ofDETC has implied that they 
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ment the crucial role played by IL-7 in maintaining 
the survival and growth ofDETC in epidermis. IL-7 
mRNA expression in keratinocytes is abrogated by 
ultraviolet B radiation. whereas it is up-regulated by 
interferon-yo which is secreted by DETC upon acti­
vation. More specifically. interferon-'}' induces the 
preferential expression of truncated forms (2.6 and 
1.5 kb) ofIL-7 transcripts. in addition to the 2.9- and 
1. 7-kb transcripts that are expressed constitutively. 
and this regulation occurs through the usage of 
alternative transcription initiation sites. These re­
sults suggest unique pathways through which IL-7 
production is regulated in keratinocytes by external 
stimllli (e.g •• ultraviolet B) as well as T-cell-derived 
cytokines (e.g •• interferon-,},). We propose that kera­
tinocyte-derived IL-7 is an essential component of 
the epidermal cytokine milieu. J Invest Dermatol 105: 
50S-53S, 1995 
most likely recognize one or a limited set of autologous antigens 
that are inducible in keratinizing epithelia [8]. This hypothesis is 
supported by several recent findings: 1) DETC can be activated in 
situ by external stimuli that cause epidermal stress [10,11]; 2) DETC 
activation is inducible in vitro by co-culturing with transformed 
keratinocytes; and 3) this activation can be blocked by anti-Vy3 
monoclonal antibody [12]. It is important that purified molecules 
from a recently recognized family of heat shock proteins failed to 
induce DETC activation [131. which suggests that the relevant 
ligand(s) for Vy3/V81 may be unique to keratinizing epithelia. 
ALTERATION OF DETC DENSITIES BY 
EXTERNAL STIMULI 
DETC populate throughout mouse skin at a relatively constant 
density comparable to that of Langer hans cells [1,2]. A fundamental 
question is how these resident leukocyte populations survive in 
epidermis, a non-lymphoid tissue. Moreover, DETC density can be 
altered in a predictable manner by various forms of external stimuli. 
For example, markedly (20-fold) increased DETC densities have 
been observed in skin sites of experimentally induced lichenoid 
reactions [10]. Surface densities also increase in response to topi­
cally applied antioxidants (e. g., butylated hydroxytoluene) [14]. 
chemical irritants (e.g., croton oil) [11], and reactive hap tens (e.g .• 
dinitrofiuorobenzene).t This increase in DETC densities most 
t Lewis JM: Origin, heterogeneity, and functional activities of murine 
dendritic epidennal T cells. Thesis, University of Texas Southwestern 
Medical School, 1991. 
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likely reflects their activation and presumably mitosis in situ, rather 
than intraepidermal migration ofDETC precursors [11]. Thus, the 
implication is that those "stressful" stimuli will trigger the expres­
sion of a relevant Iigand(s) for Vy3/V81 in neighboring keratino­
cytes which, in tum, leads to the activation ofDETC . If so, it would 
raise a second question concerning which growth factor promotes 
the mitosis of "activated" DETC. 
DETC densities may also be diminished by external stimuli, 
which include ultraviolet (UV) B radiation, 8-methoxypsoralen 
followed by UV A radiation, corticosteroids, and phorbol esters 
[15-17]. Therefore, a third question would concern whether those 
stimuli produce DETC depletion by direcdy triggering cytotoxic 
signals. causing the deficiency in relevant growth factors for DETC, 
and/or prompting the emigration ofDETC. These three questions 
will be addressed herein based on recent observations made in our 
own and other laboratories. 
DIFFERENT EPIDERMAL CELL POPULATIONS PRODUCE 
DISTINCT SETS OF CYTOKINES, THEREBY FORMING A 
UNIQUE EPIDERMAL CYTOKINE MILIEU 
Since the discovery that keratinocytes elaborate interleukin (IL)-l, 
a new concept of immunologic regulation by epidermal cytokines 
has developed. First, keratinocytes are now known to produce a 
wide variety of cytokines. including IL-la, IL-lf:l. IL-3, IL-6, IL-7, 
IL-8, IL-I0, granulocyte-macrophage colony-stimulating factor, 
tumor necrosis factor (TNF)-a, and transforming growth factors a 
and f:l (reviewed in [18-21]). Second, we and others have shown 
that Langerhans cells are capable of expressing mRNA for IL-l f:l, 
IL-6, and macrophage inflammatory protein-l a [22-25] . Finally, 
DETC secrete interferon (IFN)-y, IL-2, IL-3, and IL-4 [6,26-28]. 
Thus, different epidermal cell subpopulations produce different sets 
of cytokines, thereby forming a unique cytokine milieu within the 
epidermis. 
These epidermal cytokines play pivotal roles in mediating inter­
cellular communication among epidermal cell subpopulations. This 
concept was established originally by the earlier observations that 
granulocyte-macrophage colony-stimulating factor, IL-l, and 
TNF-a, which are produced by keratinocytes, promote the survival 
and/or maturation of Langerhans cells [29-31]. In our recent 
studies, focusing on the interaction of DETC with keratinocytes, 
we have reinforced this concept by demonstrating a pathway 
through which DETC growth is regulated by keratinocyte-derived 
cytokines (see below). 
KERATINOCYTE -DERIVED IL-7 PROMOTES 
DETCGROWTH 
IL-7 is a 25-kD polypeptide that was originally identified by its 
capacity to promote pro- and pre-B cell proliferation [8]. More 
recendy, IL-7 has been demonstrated to serve as a growth factor for 
early lymphoid cells of both B- and T-cell lineage (reviewed in 
[32]). In addition, IL-7 promotes the generation of killing activity in 
peripheral T cells [33,34] and the e.ll..l'ression of a T-cell receptor 
'Y-chain gene by pre-T cells [35]. Recent studies from our own and 
other laboratories have demonstrated that keratinocytes in both 
human and mouse constitutively express IL-7 mRNA and produce 
biologically relevant amounts ofIL-7 [36-38]. 
Based on these observations, we hypothesized that keratinocyte­
derived IL-7 may serve as a growth factor for DETC. Twelve 
diJferent epidermal cytokines were individually tested for their 
capacity to promote the growth of the 7-17 DETC line, an 
archetypic DETC line established in our laboratory [6,39]. In 
addition to IL-2, which is a known growth factor for 7-17 DETC 
[39], IL-7 exhibited a remarkable capacity to promote proliferation 
(40). The IL-7 response occurred in an IL-2-independent mecha­
nism, because IL-7-driven proliferation was blocked by anti-IL-7 
but not by anti-IL-2 antibodies, whereas IL-2-driven proliferation 
was blocked only by anti-IL-2 [38]. Moreover, the IL-2 response 
was rapid but transient, whereas the IL-7 response was rather slow 
but continuous. This difference in kinetics may relate to our 
observation that IL-2 and IL-7 activate di1ferent sets of immediate 
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Figure 1. Schematic representation of IL-7 function in mouse 
epidermis. Possible roles played by keratinocyte (KC)-derived IL-7 in 
DETC biology are shown in three diagrams. 
early genes in this cellline.:j: When tested in combination, IL-7-
induced proliferation was augmented in a synergistic fashion by 
IL-2, IL-4, or TNF-a, suggesting a pathway in which other 
epidermal cytokines enhance IL-7 response [40]. IL-7 responsive­
ness was observed not only in the 7-17 DETC line, but also in 
DETC freshly isolated from mouse skin; concanavalin-A-triggered 
proliferation of fluorescence-activated cell sorter-purified Thy-l + 
epidermal cells (i.e., DETC) was enhanced significandy by addition 
ofIL-7 [38]. Finally, culture supernatants of Pam 212 keratinocytes 
also promoted DETC growth, and this response was blocked by 
anti-IL-7 antibodies [38]. Based on these observations, we con­
cluded that keratinocyte-derived IL-7 indeed serves as a growth 
factor for DETC (Fig lA). Our current hypothesis is that IL-7 
produced locally by neighboring keratinocytes mediates in situ 
mitosis of activated DETC that occurs in response to "epidermal 
stress." 
IL-7 SUSTAINS THE SURVIVAL OF DETC BY 
PREVENTING APOPTOSIS 
When 7-17 DETC are cultured in the absence of added growth 
factors, they undergo apoptotic cell death. They also undergo 
apoptosis when treated with the physicochemical agents that are 
known to deplete DETC in vivo [15]. Treatment with UVB 
radiation, psaralen plus UV A, or dexamethasone induced rapid (less 
than 24 h) changes characteristic of apoptosis, including DNA 
fragmentation (as visualized by DNA laddering in electrophoresis), 
chromatin condensation and loss of microvilli (electron microscopic 
analyses), and requirement for macromolecular biosynthesis (inhi­
bition by cyclohexirnide).§ It is likely that these external stimuli 
cause DETC depletion ill situ, at least in part, through triggering 
apoptotic cell death in DETC. In this regard, it would be important 
to study whether these srimuli, which are also known to cause 
depletion of Langerhans cells [15], trigger apoptosis in this second 
epidermal leukocyte population. 
When exogenous IL-7 was added to 7-17 DETC culture, 
spontaneous apoptosis was no longer observed, indicating that IL-7 
sustains long-term survival of DETC [38]. Moreover, corticoste­
roids failed to induce DETC apoptosis in the presence of added 
IL-7, indicating that IL-7 prevents apoptosis triggered by external 
stimuli. Therefore, keratinocyte-derived IL-7 not only promotes 
the proliferation of DETC, but also supports their survival. This 
:j: Ariizumi K, Bergstresser PR, Takashima A: Distinct signaling pathways 
are activated by IL-2 and by IL-7 in dendritic epidennal T cells (abstr).} 
Invest Dermato/ 101:423, 1993. 
§ Matsue H, Bergstresser PRo Takashima A: Keratinocyte-derived IL-7 
rescues dendritic epidennal T cells from apoptotic cell death (abstr).} Invcst 
Dermatoll00:256,1993. 
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concept may also be applicable to a general mechanism by which yil 
T cells distribute over a wide variety of epithelial tissues; IL-7 
produced by relevant epithelial cells would allow those yil T-cell 
populations to survive in respective, non-lymphoid tissues. 
IL-7 IN THE PATHOGENESIS OF SKIN DISORDERS 
We consider DETC a prototypic T-cell population that preferen­
tially migrates into skin. In this regard, our observations described 
above imply that keratinocyte-derived IL-7 may also promote the 
survival and proliferation of inflammatory or malignant T cells that 
are recruited into skin under pathologic conditions. In this regard, 
Dalloul et al [37] have found that IL-7 is even more active than IL-2 
in its capacity to promote long-term growth of malignant T cells 
from Sezary syndrome, leading them to the establishment ofSezary 
cell lines. It is important that culture supernatants of human 
keratinocytes supported the growth of these lines, and this activity 
was blocked by anti-IL-7 antibodies [37]. More recently, Rich et al 
[41] constructed transgenic mice which expressed IL-7 cDNA that 
was coupled to an immunoglobulin promoter gene. The resulting 
IL-7 transgenic mice spontaneously developed progressive alope­
cia, which was characterized histologically by a loss of hair follicles 
and epidermal hyperplasia, accompanied by a dense infiltrate of T 
cells in the dermis [41]. These findings support our broader 
hypothesis that keratinocyte-derived IL-7 plays an important role in 
the pathogenesis of skin disorders characterized by predominant 
T-cell infiltration. 
UVB RADIATION DOWN-REGULATES IL-7 mRNA 
EXPRESSION IN KERATINOCYTES 
Having observed that DETC apoptosis is triggered by UVB radia­
tion and prevented by IL-7, we reasoned that UVB may down­
regulate IL-7 production by keratinocytes, thereby promoting this 
process of cell death. To test this hypothesis, we exposed Pam 212 
keratinocytes to UVB and measUred IL-7 mRNA expression by 
Northern blotting and RNase protection assays. In both assays, IL-7 
mRNA expression was abrogated almost completely by a relatively 
low fluence (100 Jlm2) ofUVB. This phenomenon is unique in the 
sense that UVB radiation is known to enhance the production by 
keratinocytes of many cytokines, including IL-l, IL-6, IL-l0, and 
TNF-a [18,42]. Moreover, we have observed recently that UVB­
induced DETC depletion in situ can be prevented significantly by a 
local injection of recombinant IL-7 into irradiated skin sites.1T Thus, 
it appears that UVB radiation induces DETC depletion by at least 
two mechanisms: 1) triggering of apoptosis in DETC, and 2) 
down-regulating keratinocyte production ofIL-7, which ordinarily 
prevents DETC apoptosis (Fig lB). In this regard, it is attractive to 
speculate that the same mechanisms apply for the beneficial effects 
ofUVB radiation on various dermatoses in which T-cell infiltration 
is frequently observed. 
IFN-y-DEPENDENT IL-7 GENE REGULATION 
IN KERA TINOCYTES 
The murine lL-7 gene exhibits several unique features: 1) common 
transcriptional regulatory sequences (e.g., TATA box, CAAT 
sequences, Sp1, or GC-rich regions) have not yet been identified 
[43]; 2) multiple lL-7 mRNA species of 2.9, 2.6, 1.7, and 1.5 
kilobase pairs (kb) have been detected in a tissue-specific fashion 
[8]; and 3) the original IL-7 cDNA clone, 1046, contained eight 
potential translation initiation codons in its long 5' untranslated 
region, and this feature appears to be responsible for its poor 
translational activity [8]. These features, not commonly observed 
with other cytokine genes, suggest that IL-7 production is regulated 
by several mechanisms at both the transcriptional and translational 
level. 
We have studied IL-7 gene regulation in keratinocytes, focusing 
on the influence of epidermal cytokines. Pam 212 keratinocytes 
� Takashlma A, Ariizumi K, Ellinger L, Bergstresser PR: Mechanisms for 
UVB-induced depletion of dendritic epidermal T cells (abstr). J Invest 
DermatoI101:404, 1993. 
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expressed constitutively two major IL-7 mRNA species of2.9 and 
1.7 kb and two minor transcripts that were 2.7 and 1.5 kb . This 
profile ofIL-7 mRNA expression by keratinocytes is similar to that 
observed in the thymus but differs from that of kidney, where the 
2.9-kb species predominates [8]. When cells were incubated for 16 
h with IFN-y, the 2.6- and 1.5-kb transcripts became dominant, 
whereas expression of the 2.9- and 1.7-kb transcripts remained 
relatively unchanged. We have also found that the 2.6- and 1.5-kb 
mRNAs are produced through the usage of alternative transcription 
initiation sites; these mRNAs are transcribed within 250 bp from 
the coding sequence, whereas 2.9- and 1.7-kb mRNAs contain 
more than 400 bases in the 5' untranslated region. IFN-y appears to 
promote this conversion through the IFN-stimulated response 
element, which is located 270 base pairs upstream from the coding 
sequence. * * An attractive hypothesis is that this truncation in the 5' 
UTR may result in increased translational activity of the IL-7 
transcript through deletion of a translationally inhibitory region. IT 
so, these results would illnstrate a unique pathway in which DETC 
(and infiltrating T cells) up-regulate, through the elaboration of 
IFN-y, the production of their growth factor (i.e., IL-7) by 
keratinocytes (Fig lC). 
CONCLUDING REMARKS 
Cytokines playa regulatory role in the induction, amplification, and ' 
resolution of immunologic reactions. Among various cytokines 
produced locally in the epidermis, IL-7 appears to control the 
function of T cells in the epidermal microenvironment. To elabo­
rate this concept, we must study the regulation of IL-7 production 
in keratinocytes, the capacity of IL-7 to modulate other functional 
properties ofT cells recruited into epidermis, and the expression of 
IL-7 receptors on those T cells. We believe that these studies will 
ultimately lead to the development of new therapeutic modalities 
applicable to the treatment of inflammatory as well as malignant 
skin disorders. 
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